Rznomics
Gwangju
About Rznomics
This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $64.5M
- Funding stage: IPO
- Last round: Series Unknown (Sep 2024)
- Ticker: kosdaq:476830
- Website: rznomics.com
- Phone: +82 62-974-2905
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/rznomics-86995 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.